Tread Carefully Into Virtual Clinical Trials
Tread Carefully Into Virtual Clinical Trials By Ed Miseta, Chief Editor, Clinical Leader Follow Me On Twitter @EdClinical With the COVID-19 pandemic’s impact on clinical trials in the U.S. and around the world, everyone is suddenly focused on virtual (decentralized) clinical trials. But if you plan to move your trials to a virtual model, at least one industry executive is recommending that you use caution when doing so. “Everyone wants to migrate to virtual trials, but when doing so I think we need to be careful,” says Jeff Kasher, president of Patients Can’t Wait. “It’s important...
Source: clinicalleader.com